Back to dashboard
CommercialReimbursementMedium impact

00.01.73, Reimbursement of Surgical Pathology Services for Prostate Biopsy

Independence Blue Cross·Urology, Pathology·Claims & Billing
Effective date
Mar 2, 2026
We identified it
Jun 19, 2026
Days to comply

Summary

A new policy has been established for the reimbursement of surgical pathology services specifically for prostate biopsy procedures. This policy will govern how commercial insurance plans handle coverage and payment for pathology services related to prostate biopsies.

Action Required

Action needed
By March 2, 2026: Billing team must review and implement the new reimbursement guidelines for surgical pathology services related to prostate biopsies. Update billing protocols and fee schedules for commercial plans. Ensure compliance with the new policy requirements to avoid claim denials for prostate biopsy pathology services.